Skip to main content
Top
Published in:

Open Access 09-05-2024 | Fibromyalgia | Observational Research

The effect of earthquake on fibromyalgia: a comparison of patients on medication and without medication

Authors: Gulsah Yasa Ozturk, Neval Bozok Arat, Asena Ayca Ozdemir, Ibrahim Bashan, Burhan Fatih Kocyigit

Published in: Rheumatology International | Issue 7/2024

Login to get access

Abstract

Introduction / objectives

Stressful events like earthquakes might worsen the symptoms of fibromyalgia, although the influence of medications on these consequences is yet uncertain. The objective of this study was to examine the influence of an earthquake on the symptoms of fibromyalgia and evaluate the impacts of medications used to treat fibromyalgia on the clinical picture.

Method

Ninety-five fibromyalgia patients were enrolled in a comparative study and divided into two groups: medication and non-medication. Three subcategories of medication groups were established: selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and gabapentinoid drugs (GDs). Before and after the earthquake, clinical evaluations were conducted using the Fibromyalgia Impact Questionnaire (FIQ), Hospital Anxiety and Depression Scale (HADS), and Jenkins Sleep Rating Scale (JSS). Statistical analyses were conducted to compare the scores before and after the earthquake and evaluate the differences between the groups.

Results

Statistically significant increases were observed in FIQ, HADS-anxiety, HADS-depression, and JSS scores in the medication and non-medication groups before and after the earthquake comparisons (p < 0.05). Non-medication group reported significantly higher post-earthquake changes in FIQ, HADS-anxiety, HADS-depression, and JSS compared to the medication group (p < 0.05). While HADS-anxiety, HADS-depression, and JSS changes after the earthquake differed according to the drug subgroups (p < 0.05), no statistically significant difference was observed in FIQ values (p > 0.05). The highest scores were detected in the GD subgroup.

Conclusions

This study highlights the substantial impact of earthquakes on fibromyalgia patients. Medication use may assist in reducing the detrimental effects of stresses like earthquakes on fibromyalgia symptomatology. Future research with larger sample sizes and more extended follow-up periods is needed to explain these findings and optimize treatment regimens for fibromyalgia patients experiencing significant stressors.
Appendix
Available only for authorised users
Literature
14.
go back to reference Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728–733PubMed Burckhardt CS, Clark SR, Bennett RM (1991) The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18:728–733PubMed
17.
go back to reference Aydemir Ö, Güvenir T, Kuey L, Kültür S (1997) Validity and reliability of Turkish version of hospital anxiety and Depression Scale. Turk Psikiyatri Derg 8:280–287 Aydemir Ö, Güvenir T, Kuey L, Kültür S (1997) Validity and reliability of Turkish version of hospital anxiety and Depression Scale. Turk Psikiyatri Derg 8:280–287
23.
go back to reference Salaffi F, Atzeni F, Talotta R, Di Carlo M, Sarzi-Puttini P (2017) Earthquake vulnerability of fibromyalgia patients: six-month follow-up after the catastrophic disasters in central Italy. Clin Exp Rheumatol 35(Suppl 105):93–99PubMed Salaffi F, Atzeni F, Talotta R, Di Carlo M, Sarzi-Puttini P (2017) Earthquake vulnerability of fibromyalgia patients: six-month follow-up after the catastrophic disasters in central Italy. Clin Exp Rheumatol 35(Suppl 105):93–99PubMed
Metadata
Title
The effect of earthquake on fibromyalgia: a comparison of patients on medication and without medication
Authors
Gulsah Yasa Ozturk
Neval Bozok Arat
Asena Ayca Ozdemir
Ibrahim Bashan
Burhan Fatih Kocyigit
Publication date
09-05-2024
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 7/2024
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-024-05605-5

Other articles of this Issue 7/2024

Rheumatology International 7/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare